1Biometry Research Group, National Cancer Institute, Executive Plaza North, Suite 3131, 6130 Executive Blvd, MSC 7354, Bethesda, MD 20892-7354, USA. ph107y@nih.gov
This study examines early detection clinical trials for asymptomatic individuals. Key factors influencing trial power include screening frequency, timing, and participant age, impacting study design and results.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: